## Abstract Tissue inhibitor of metalloproteinasesβ4 (TIMPβ4), the newest member of the TIMP family, blocks the activities of several matrix metalloproteinases (MMPs) implicated in the arthritic cartilage erosion. By utilizing semiβquantitative RTβPCR, immunoblotting, and immunohistochemistry, we i
Expression of the tissue inhibitor of metalloproteinases (TIMP) gene family in normal and osteoarthritic joints
β Scribed by S. Su; J. Grover; P. J. Roughley; J. A. DiBattista; J. Martel-Pelletier; J.-P. Pelletier; M. Zafarullah
- Publisher
- Springer
- Year
- 1999
- Tongue
- English
- Weight
- 328 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0172-8172
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Tissue inhibitors of metalloproteinases (TIMPs) inhibit the extracellular matrix (ECM) metalloproteinases (MMPs). To determine the source of TlMPs in synovial fluids of patients with osteoarthritis (OA), the ability of chondrocytes to express TIMP-2 and its regulation by agents found in inflammed jo
Tissue inhibitor of metalloproteinases-I (TIMP-I) is known to have at least 2 distinct types of activity, i.e., as a regulator of collagenolytic activity, and erythroid potentiating activity (EPA). In this study, we examined the expression of TIMP-I in human mammary carcinomas, non-malignant breast
Degradation of the extracellular matrix (ECM) is an essential step in tumour invasion and metastasis. The matrix metalloproteinases (MMPs) each have different substrate specificities within the ECM and are important in its degradation. MMP activity is dependent on the levels of activated MMP and tis
Rous sarcoma virus-transformed chicken embryo fibroblasts (RSVCEF), when compared to normal CEF, produce elevated levels of matrix metalloproteinase-2 (MMP-2) that exists in a form free of complexed tissue inhibitor of metalloproteinase-2 (TIMP-2). In order to ascertain whether the increased levels